Ardelyx (ARDX) (ADRX) announced the appointment of Sue Hohenleitner as Chief Financial Officer, CFO, effective November 4, 2025. Hohenleitner most recently served as the Vice President and Chief Financial Officer of Johnson & Johnson (JNJ) Innovative Medicine North America
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX: